Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEODEC neostigmine dose comparison for advanced reversal of neuromuscular blockade
2008-008046-21Phase 3Active
- Sponsor
- CHD Vendée
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of neostigmine in Postoperative residual curarization (PORC) (4 arms), sponsored by CHD Vendée. Primary endpoints: Time from neostigmine injection to first train-of-four ratio at or above 100% and Train-of-four ratio assessment. Started Mar 2009; status: active.
02
Drugs
neostigmine
03
Conditions
Postoperative residual curarization (PORC)
Beyond the preview
Go deeper on 2008-008046-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008046-21.